Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2005 Sep;69(3):373-92.
doi: 10.1128/MMBR.69.3.373-392.2005.

Laboratory-directed protein evolution

Affiliations
Review

Laboratory-directed protein evolution

Ling Yuan et al. Microbiol Mol Biol Rev. 2005 Sep.

Abstract

Systematic approaches to directed evolution of proteins have been documented since the 1970s. The ability to recruit new protein functions arises from the considerable substrate ambiguity of many proteins. The substrate ambiguity of a protein can be interpreted as the evolutionary potential that allows a protein to acquire new specificities through mutation or to regain function via mutations that differ from the original protein sequence. All organisms have evolutionarily exploited this substrate ambiguity. When exploited in a laboratory under controlled mutagenesis and selection, it enables a protein to "evolve" in desired directions. One of the most effective strategies in directed protein evolution is to gradually accumulate mutations, either sequentially or by recombination, while applying selective pressure. This is typically achieved by the generation of libraries of mutants followed by efficient screening of these libraries for targeted functions and subsequent repetition of the process using improved mutants from the previous screening. Here we review some of the successful strategies in creating protein diversity and the more recent progress in directed protein evolution in a wide range of scientific disciplines and its impacts in chemical, pharmaceutical, and agricultural sciences.

PubMed Disclaimer

References

    1. Abecassis, V., D. Pompon, and G. Truan. 2000. High efficiency family shuffling based on multi-step PCR and in vivo DNA recombination in yeast: statistical and functional analysis of a combinatorial library between human cytochrome P450 1A1 and 1A2. Nucleic Acids Res. 28:E88. - PMC - PubMed
    1. Agrawal, V., and R. K. Kishan. 2001. Functional evolution of two subtly different (similar) folds. BMC Struct. Biol. 1:5. - PMC - PubMed
    1. Aharonowitz, Y., and G. Cohen. 1981. The microbiological production of pharmaceuticals. Sci. Am. 245:140-152. - PubMed
    1. Alcalde, M., E. T. Farinas, and F. H. Arnold. 2004. Colorimetric high-throughput assay for alkene epoxidation catalyzed by cytochrome P450 BM-3 variant 139-3. J. Biomol. Screen. 9:141-146. - PubMed
    1. Anthony-Cahill, S. J., and T. J. Magliery. 2002. Expanding the natural repertoire of protein structure and function. Curr. Pharm. Biotechnol. 3:299-315. - PubMed

Publication types

MeSH terms

LinkOut - more resources